Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | S100A4 | P26447 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3110322 | 0.85 | KMT2A (0.44) | PTGDR2KMT2AMEN1RXFP1CYP1A2 | |
| SCHEMBL12539016 | 0.82 | MEN1 (0.41) | KMT2AMEN1 | |
| SCHEMBL13642178 | 0.80 | MGLL (0.50) | KMT2AMEN1PTGS2LMNABACE1 | |
| SCHEMBL31576793 | 0.80 | MGLL (0.50) | KMT2AMEN1PTGS2LMNABACE1 | |
| SCHEMBL19464511 | 0.78 | HDAC7 (0.49) | PTGDR2KMT2AMEN1CHRM1LMNA | |
| SCHEMBL3106470 | 0.78 | MAP2 (0.43) | KMT2AMEN1CYP1A2S100A4HTR2C | |
| SCHEMBL25320059 | 0.77 | PTGDR2 (0.45) | PTGDR2MAPK1LMNABACE1MAPT | |
| SCHEMBL28489366 | 0.77 | BACE1 (0.40) | KMT2AMEN1CYP1A2HTR2CPTGS2 | |
| SCHEMBL28545275 | 0.77 | METAP2 (0.37) | PTGDR2KMT2AMEN1RXFP1CYP1A2 | |
| SCHEMBL29664280 | 0.76 | SLC6A4 (0.47) | KMT2AMEN1CYP1A2PTGS2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025135767-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 솔루스첨단소재 주식회사 | 2025-06-26 | — | — | WO | disclosed |
| US-20240373745-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2024-11-07 | — | — | US | disclosed |
| CN-116444435-B | Fluorene derivative, electronic element and electronic device | 浙江八亿时空先进材料有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-116444435-A | Fluorene derivative, electronic element and electronic device | 浙江八亿时空先进材料有限公司 | 2023-07-18 | — | — | CN | disclosed |
| US-20230183191-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-15 | — | — | US | disclosed |
| US-20230183191-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-15 | — | — | US | disclosed |
| WO-2022262365-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE COMPRISING SAME | 陕西莱特光电材料股份有限公司 | 2022-12-22 | — | — | WO | disclosed |
| US-10833276-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-11-10 | — | — | US | disclosed |
| US-20180145262-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2018-05-24 | — | — | US | disclosed |
| US-20180145262-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10833276-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, TYR | PTGDR2 4334/4885KMT2A 3047/4885MEN1 4256/4885 |
| US-20230183191-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | CNOT1, NXF1, NR2E1 | PTGDR2 2680/4885KMT2A 2134/4885MEN1 1030/4885 |
| US-20180145262-A1 | Organic Electroluminescent Materials and Devices | OCIAD2, OCIAD1, TYR | PTGDR2 4334/4885KMT2A 3047/4885MEN1 4256/4885 |
| US-20240373745-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | RER1, RPS19, ESRRA | PTGDR2 1057/4885KMT2A 1538/4885MEN1 1012/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.